GSK and other drugmakers fending off litigation claiming that gastrointestinal drug Zantac or a generic caused cancer have won a supreme court ruling in Canada, after also chalking up wins in the US.

Shares in GSK fell around 9% this morning after ... of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial. Judge Vivian Medinilla of Delaware Superior Court issued an ...

Some Delaware Supreme Court justices signaled they may be skeptical of a bid by GSK Plc ... lawsuits to proceed to trial over claims that the heartburn drug Zantac is linked to cancer.

GSK has shared the data behind its phase 3 liver disease win, revealing patients on linerixibat reported reductions in ...

GSK plc (NYSE:GSK) met the main goal in a late-stage trial of linerixibat, a treatment for cholestatic pruritus, a severe itching condition caused by an autoimmune liver disease called ...

GSK and iTeos are the latest companies to scrap a jointly developed anti-TIGIT drug after it failed to demonstrate a meaningful benefit in two Phase II trials. Belrestotug, a human IgG1 antibody ...

who did not know that GSK had for decades concealed an internal study that implicated the Company's liability to Zantac users; and (4) as a result, Defendants' positive statements about the ...

In September and October 2019, GSK suspended its distribution of Zantac (the brand name for the drug ranitidine) and issued a voluntary recall after studies demonstrated that, by interacting with ...

CONTACT US HERE: ALLEGATIONS: According to the filed complaint, defendants represented to investors that GSK removed Zantac from the market "[b]ased on information available at the time and ...